Clinical Trial Update: 3-Dimensional Mapping System: The PULSTAR Study [NA]

View source ↗

Summary

The PULSTAR Study evaluating a 3-Dimensional Mapping System for paroxysmal atrial fibrillation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Paroxysmal Atrial Fibrillation

Snippet

Sponsor: Shanghai Shangyang Medical Technology Co., Ltd. | Conditions: Paroxysmal Atrial Fibrillation | NA | Status: COMPLETED